Viewing StudyNCT03202667



Ignite Creation Date: 2024-05-06 @ 10:14 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03202667
Status: COMPLETED
Last Update Posted: 2021-12-13
First Post: 2017-06-27

Brief Title: Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study
Sponsor: University Hospital Basel Switzerland
Organization: University Hospital Basel Switzerland

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-12-15
Start Date Type: ACTUAL
Primary Completion Date: 2021-08-26
Primary Completion Date Type: ACTUAL
Completion Date: 2021-12-06
Completion Date Type: ACTUAL
First Submit Date: 2017-06-27
First Submit QC Date: June 27 2017
Study First Post Date: 2017-06-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-12-10
Last Update Post Date: 2021-12-13
Last Update Post Date Type: ACTUAL